10 biotech consultants

Experience: President and Principal Consultant · Proventus Consulting LLC

President and Principal Consultant at Proventus Consulting LLC since 2017, advising biotech and pharmaceutical CEOs and executive teams, primarily in oncology, on enterprise commercial strategy, launch readiness and value creation across the asset lifecycle. The profile lists Senior Global Commercial Leadership Roles, Oncology at Eli Lilly and Company (1990–2017) and Board Member at AVIPERO Bio since 2022.

Experience: CEO, Founder, Biotechnology Pharmaceutical Consultant · Hughes BioPharma Advisers LLC Clinical Operations Consulting

CEO, Founder, Biotechnology Pharmaceutical Consultant at Hughes BioPharma Advisers LLC Clinical Operations Consulting since 2005; the profile highlights R&D operations, clinical trials, risk and audit work and deep expertise in clinical product development. She was Biopharma Life Sciences Adviser at NeoTelos Inc. (2024–2025) and Senior Management Consultant, R&D Operational Process, GXP SME (Hughes BioPharma) at STEP-IN MANAGEMENT LTD (2020–2022).

Experience: Managing Director · Bourk BioAdvisors

Managing Director of Bourk BioAdvisors since 2025. The profile says he partners with biotech founders and executive teams on strategies, drawing on business development, commercial strategy and program leadership. He was VP, Head of Business Development at Adaptimmune (2024–2025) and Chief Business Officer & Head of External Innovation at Chimeric Therapeutics (2022–2024).

Experience: Founder & Principal, Biopharma Commercial & Strategy Consulting Practice · Paula Keebler Advisory

Founder & Principal, Biopharma Commercial & Strategy Consulting Practice at Paula Keebler Advisory since 2018. The profile describes helping biopharma organizations turn complex pipelines into clear, actionable plans, with a focus on product strategy, launch readiness, rare disease and oncology. It also lists VP Business Development and Corporate Strategy at 4D Molecular Therapeutics (2019).

Experience: Chief Executive Officer · PBA BIOTECH CONSULTING

Former Chief Executive Officer of PBA BIOTECH CONSULTING (2003–2019). The profile says he founded PBA Biotech Consulting SAS in 2003 as an independent consulting firm and has advised more than 150 venture capital firms, life sciences companies and project holders on their corporate strategy and on raising capital.

Experience: Independent Life Sciences Strategy Advisor · Independent Consultant

Independent Life Sciences Strategy Advisor since 2026. He was Executive Director at Protagoras Group (2024–2026), Partner at Vintura (2020–2024) and Director, Life Science Strategy at Navigant (2017–2020). The profile says he helps biotech and pharma companies maximise asset value, including which assets to prioritise, how to design development strategies and when to invest, partner or pivot.

Experience: Biotechnology Strategy Consultant · Rbeiz Bio Consulting

Biotechnology Strategy Consultant at Rbeiz Bio Consulting since 2023, providing commercial and strategic consulting for late clinical stage biotechnology companies and large multinational pharmaceutical companies, focused on global launch, market shaping, product and program strategies. She was VP, Program Strategy Leader FTX-6058 a.i. (2022–2023) and Vice President, Head of Commercial Brand Team, FSHD (2022–2023) at Fulcrum Therapeutics.

Experience: Founder & Principal Consultant Biotech & Pharma Strategy, Commercial Excellence & B2B Sales · Swiss Consulting & Strategy

Founder & Principal Consultant Biotech & Pharma Strategy, Commercial Excellence & B2B Sales at Swiss Consulting & Strategy since 2026, and External Advisor Commercial Strategy & Business Development at Genedata since 2026. He was Head of Sales at Genedata (2019–2026). The profile describes him as a strategic consultant to the biotechnology and pharmaceutical industry who helps organizations optimize commercial performance and navigate complex market dynamics.

Experience: Founder and Consultant · Prestwick Advisory

Founder and Consultant at Prestwick Advisory since 2026, a specialist consultancy serving the pharmaceutical and life sciences sector; the profile says he advises biotech and pharma companies on business development, partnership strategy and commercial execution. He was Chief Executive Officer and Managing Director of QBiotics Group Limited (2024–2025) and Chief Business Officer at ASLAN Pharmaceuticals (2019–2024).

Experience: Principal Consultant & Life Sciences Advisor · StratPlanX Biopharm Consulting, LLC

Principal Consultant & Life Sciences Advisor at StratPlanX Biopharm Consulting, LLC since 2025, providing fractional leadership and advisory services to small and emerging life sciences firms to maximize asset and company value. He was Vice President, Business Operations at ReAlta Life Sciences (2023–2024) and Vice President, Portfolio & Program Management at Aura Biosciences (2021–2023).